Home
Pascal Francois Gelebart's picture

Pascal Francois Gelebart

Researcher
  • E-mailpascal.gelebart@uib.no
  • Visitor Address
    Haukeland universitetssykehus, Laboratoriebygget
    5009 Bergen
  • Postal Address
    Postboks 7804
    5020 Bergen
Academic article
  • Show author(s) (2024). Sarco/endoplasmic reticulum calcium ATPase 3 (SERCA3) expression in gastrointestinal stromal tumours. Pathology (Sydney).
  • Show author(s) (2023). Inhibition of a new AXL isoform, AXL3, induces apoptosis of mantle cell lymphoma cells. Blood. 1478-1493.
  • Show author(s) (2021). Gene Methylation and Silencing of WIF1 Is a Frequent Genetic Abnormality in Mantle Cell Lymphoma. International Journal of Molecular Sciences. 10 pages.
  • Show author(s) (2020). Stabilization of β-catenin upon B-cell receptor signaling promotes NF-kB target genes transcription in mantle cell lymphoma. Oncogene.
  • Show author(s) (2018). A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications. 1-14.
  • Show author(s) (2016). Xenograft models of primary acute myeloid leukemia for the development of imaging strategies and evaluation of novel targeted therapies. Current Pharmaceutical Biotechnology. 42-51.
Academic lecture
  • Show author(s) (2022). Establishment of peritoneal dECM scaffolds for culture of ovarian cancer organoids.
  • Show author(s) (2022). Establishment of ovarian cancer organoids on peritoneal dECM scaffolds.
Masters thesis
  • Show author(s) (2018). Preclinical development of novel therapeutics in mantle cell lymphoma.
  • Show author(s) (2017). Exploration of novel therapeutic options in mantle cell lymphoma.
Letter to the editor
  • Show author(s) (2021). Preclinical characterisation and development of a novel myelodysplastic syndrome-derived cell line. British Journal of Haematology. 415-427.
Academic chapter/article/Conference paper
  • Show author(s) (2022). Modeling the Tumor Microenvironment in Patient-Derived Xenografts: Challenges and Opportunities. 16 pages.
Poster
  • Show author(s) (2022). Establishment of peritoneal dECM scaffolds for 3D culture of ovarian cancer organoids.
Errata
  • Show author(s) (2023). Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage (Nature Communications, (2018), 9, 1, (1107), 10.1038/s41467-018-03441-3). Nature Communications.
  • Show author(s) (2018). Publisher Correction: A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage. Nature Communications.
Academic literature review
  • Show author(s) (2020). Endoplasmic reticulum calcium pumps and tumor cell differentiation. International Journal of Molecular Sciences. 1-25.

More information in national current research information system (CRIStin)